Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Reversible chronic pulmonary fibrosis associated with MMF in a pediatric patient: a case report.

Reynolds BC, Paton JY, Howatson AG, Ramage IJ.

Pediatr Transplant. 2008 Mar;12(2):228-31. doi: 10.1111/j.1399-3046.2007.00707.x.

PMID:
18307673
2.

Mycophenolate Mofetil and Pulmonary Fibrosis After Kidney Transplantation: A Case Report.

Takahashi K, Go P, Stone CH, Safwan M, Putchakayala KG, Kane WJ, Malinzak LE, Kim DY, Denny JE.

Am J Case Rep. 2017 Apr 14;18:399-404.

3.

Pulmonary fibrosis secondary to administration of mycophenolate mofetil.

Morrissey P, Gohh R, Madras P, Monaco AP.

Transplantation. 1998 May 27;65(10):1414. No abstract available.

PMID:
9625032
4.

Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.

Staskewitz A, Kirste G, Tönshoff B, Weber LT, Böswald M, Burghard R, Helmchen U, Brandis M, Zimmerhackl LB.

Transplantation. 2001 Mar 15;71(5):638-44.

PMID:
11292293
5.

Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil.

Gross DC, Sasaki TM, Buick MK, Light JA.

Transplantation. 1997 Dec 15;64(11):1607-9.

PMID:
9415567
6.

Therapeutic idiosyncrasy.

Sweet SC.

Pediatr Transplant. 2008 Mar;12(2):121-2. Epub 2007 Dec 16. No abstract available.

PMID:
18086249
7.

Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.

Cransberg K, Cornelissen M, Lilien M, Van Hoeck K, Davin JC, Nauta J.

Transplantation. 2007 Apr 27;83(8):1041-7.

PMID:
17452893
8.

Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.

Grinyó JM, Gil-Vernet S, Cruzado JM, Caldés A, Riera L, Serón D, Rama I, Torras J.

Transpl Int. 2003 Nov;16(11):820-7. Epub 2003 Jul 22.

9.

Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.

Höcker B, Weber LT, Bunchman T, Rashford M, Tönshoff B; Tricontinental MMF Suspension Study Group.

Pediatr Transplant. 2005 Aug;9(4):504-11.

PMID:
16048604
10.

Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.

Tedoriya T, Keogh AM, Kusano K, Savdie E, Hayward C, Spratt PM, Wilson M, Macdonald PS.

J Heart Lung Transplant. 2002 Sep;21(9):976-82.

PMID:
12231368
11.

Mycophenolate mofetil without antibody induction in cadaver vs. living donor pediatric renal transplantation.

Ojogho O, Sahney S, Cutler D, Baron PW, Abdelhalim FM, Hasan SM, Concepcion W.

Pediatr Transplant. 2003 Apr;7(2):137-41.

PMID:
12654055
12.

Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection.

Butani L, Palmer J, Baluarte HJ, Polinsky MS.

Transplantation. 1999 Jul 15;68(1):83-6.

PMID:
10428272
14.

The use of mycophenolate mofetil suspension in pediatric renal allograft recipients.

Bunchman T, Navarro M, Broyer M, Sherbotie J, Chavers B, Tönshoff B, Birk P, Lerner G, Lirenman D, Greenbaum L, Walker R, Zimmerhackl LB, Blowey D, Clark G, Ettenger R, Arterburn S, Klamerus K, Fong A, Tang H, Thomas S, Ramos E.

Pediatr Nephrol. 2001 Dec;16(12):978-84.

16.
17.

Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil.

Ferraris JR, Ghezzi LF, Vallejo G, Piantanida JJ, Araujo JL, Sojo ET.

Pediatr Transplant. 2005 Apr;9(2):178-82.

PMID:
15787789
18.

Clinically "silent" weight loss associated with mycophenolate mofetil in pediatric renal transplant recipients.

Laskin B, Goebel J.

Pediatr Transplant. 2008 Feb;12(1):113-6. doi: 10.1111/j.1399-3046.2007.00840.x.

PMID:
18186899
19.

Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: relationship with corticosteroid dosage, renal function, sex, and patient age.

Puig JM, Fernández-Crespo P, Lloveras J, Mir M, Iñigo V, Manresa JM, Masramón J.

Transplant Proc. 1999 Sep;31(6):2270-1. No abstract available.

PMID:
10500572
20.

Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation.

Waiser J, Schötschel R, Budde K, Neumayer HH.

Am J Kidney Dis. 2000 Mar;35(3):E12.

PMID:
10692297

Supplemental Content

Support Center